Literature DB >> 27656773

Cystinosin-LKG rescues cystine accumulation and decreases apoptosis rate in cystinotic proximal tubular epithelial cells.

Anna Taranta1, Francesco Bellomo1, Stefania Petrini2, Elena Polishchuk3, Ester De Leo1, Laura Rita Rega1, Anna Pastore4, Roman Polishchuk3, Maria Antonietta De Matteis3, Francesco Emma1.   

Abstract

BACKGROUND: Nephropathic cystinosis is a lysosomal storage disease that is caused by mutations in the CTNS gene encoding a cystine/proton symporter cystinosin and an isoform cystinosin-LKG which is generated by an alternative splicing of exon 12. We have investigated the physiological role of the cystinosin-LKG that is widely expressed in epithelial tissues.
METHODS: We have analyzed the intracellular localization and the function of the cystinosin-LKG conjugated with DsRed (cystinosin-LKG-RFP) in Madin-Darby canine kidney cells (MDCK II) and in proximal tubular epithelial cells carrying a deletion of the CTNS gene (cystinotic PTEC), respectively.
RESULTS: Cystinosin-LKG-RFP colocalized with markers of lysosomes, late endosomes and was also expressed on the apical surface of polarized MDCK II cells. Moreover, immune-electron microscopy images of MDCK II cells overexpressing cystinosin-LKG-RFP showed stacked lamellar membranes inside perinuclear lysosomal structures. To study the role of LKG-isoform, we have investigated cystine accumulation and apoptosis that have been described in cystinotic cells. Cystinosin-LKG decreased cystine levels by approximately 10-fold similarly to cystinosin-RFP. The levels of TNFα- and actinomycin D-inducted apoptosis dropped in cystinotic cells expressing LKG-isoform. This effect was also similar to the main isoform.
CONCLUSION: Our results suggest that cystinosin-LKG and cystinosin move similar functional activities in cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27656773     DOI: 10.1038/pr.2016.184

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

2.  Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis.

Authors:  Ahmed Reda; Koenraad Veys; Prashant Kadam; Anna Taranta; Laura Rita Rega; Bianca M Goffredo; Chelsea Camps; Martine Besouw; Daniel Cyr; Maarten Albersen; Carl Spiessens; Liesbeth de Wever; Robert Hamer; Mirian C H Janssen; Kathleen D'Hauwers; Alex Wetzels; Leo Monnens; Lambertus van den Heuvel; Ellen Goossens; Elena Levtchenko
Journal:  J Inherit Metab Dis       Date:  2021-09-24       Impact factor: 4.750

3.  Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic Cystinosis.

Authors:  Francesco Bellomo; Ester De Leo; Anna Taranta; Laura Giaquinto; Gianna Di Giovamberardino; Sandro Montefusco; Laura Rita Rega; Anna Pastore; Diego Luis Medina; Diego Di Bernardo; Maria Antonietta De Matteis; Francesco Emma
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

4.  Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis.

Authors:  Domenico De Rasmo; Anna Signorile; Ester De Leo; Elena V Polishchuk; Anna Ferretta; Roberto Raso; Silvia Russo; Roman Polishchuk; Francesco Emma; Francesco Bellomo
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

Review 5.  Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?

Authors:  Lorenzo A Calò; Paul A Davis
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

6.  Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis.

Authors:  Anna Taranta; Mohamed A Elmonem; Francesco Bellomo; Ester De Leo; Sara Boenzi; Manoe J Janssen; Amer Jamalpoor; Sara Cairoli; Anna Pastore; Cristiano De Stefanis; Manuela Colucci; Laura R Rega; Isabella Giovannoni; Paola Francalanci; Lambertus P van den Heuvel; Carlo Dionisi-Vici; Bianca M Goffredo; Rosalinde Masereeuw; Elena Levtchenko; Francesco Emma
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.